Stanley T Crooke - Net Worth and Insider Trading
Stanley T Crooke Net Worth
The estimated net worth of Stanley T Crooke is at least $17 Million dollars as of 2025-05-03. Stanley T Crooke is the Exec Chairman of the Board of Ionis Pharmaceuticals Inc and owns about 499,523 shares of Ionis Pharmaceuticals Inc (IONS) stock worth over $16 Million. Stanley T Crooke is also the Director, 10% Owner of Regulus Therapeutics Inc and owns about 58,746 shares of Regulus Therapeutics Inc (RGLS) stock worth over $461,156. Details can be seen in Stanley T Crooke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stanley T Crooke has not made any transactions after 2021-01-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stanley T Crooke
Stanley T Crooke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stanley T Crooke owns 3 companies in total, including Ionis Pharmaceuticals Inc (IONS) , Akcea Therapeutics Inc (AKCA) , and Regulus Therapeutics Inc (RGLS) .
Click here to see the complete history of Stanley T Crooke’s form 4 insider trades.
Insider Ownership Summary of Stanley T Crooke
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2021-01-26 | director & Chairman & President & CEO |
| AKCA | Akcea Therapeutics Inc | 2017-07-13 | director |
| RGLS | Regulus Therapeutics Inc | 2012-10-10 | director & 10 percent owner |
Stanley T Crooke Latest Holdings Summary
Stanley T Crooke currently owns a total of 2 stocks. Among these stocks, Stanley T Crooke owns 499,523 shares of Ionis Pharmaceuticals Inc (IONS) as of January 26, 2021, with a value of $16 Million and a weighting of 97.26%. Stanley T Crooke also owns 58,746 shares of Regulus Therapeutics Inc (RGLS) as of October 10, 2012, with a value of $461,156 and a weighting of 2.74%.
Latest Holdings of Stanley T Crooke
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2021-01-26 | 499,523 | 32.78 | 16,374,364 |
| RGLS | Regulus Therapeutics Inc | 2012-10-10 | 58,746 | 7.85 | 461,156 |
Holding Weightings of Stanley T Crooke
Stanley T Crooke Form 4 Trading Tracker
According to the SEC Form 4 filings, Stanley T Crooke has made a total of 9 transactions in Ionis Pharmaceuticals Inc (IONS) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Ionis Pharmaceuticals Inc is the sale of 28,333 shares on January 26, 2021, which brought Stanley T Crooke around $2 Million.
According to the SEC Form 4 filings, Stanley T Crooke has made a total of 0 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years. The most-recent trade in Regulus Therapeutics Inc is the acquisition of 6,250 shares on October 10, 2012, which cost Stanley T Crooke around $3 Million.
Insider Trading History of Stanley T Crooke
- 1
Stanley T Crooke Trading Performance
GuruFocus tracks the stock performance after each of Stanley T Crooke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stanley T Crooke is 36.87%. GuruFocus also compares Stanley T Crooke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stanley T Crooke within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stanley T Crooke's insider trading performs compared to the benchmark.
Performance of Stanley T Crooke
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.31 | | | | | |
| Relative Return to S&P 500(%) | 21.99 | | | | | |
Stanley T Crooke Ownership Network
Ownership Network List of Stanley T Crooke
Ownership Network Relation of Stanley T Crooke
Stanley T Crooke Owned Company Details
What does Ionis Pharmaceuticals Inc do?
Who are the key executives at Ionis Pharmaceuticals Inc?
Stanley T Crooke is the director & Chairman & President & CEO of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include EVP & Corp and Development Ops Brian Birchler , Chief Business Officer Joseph Baroldi , and director & Senior Vice President Brett P Monia .
Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary
Over the past 18 months, Stanley T Crooke made no insider transaction in Ionis Pharmaceuticals Inc (IONS). Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 246,346 shares made by Brett P Monia , a net sale of 55,113 shares made by Patrick R. O'neil , and a net sale of 44,078 shares made by Richard S Geary .
In summary, during the past 3 months, insiders sold 53,979 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 15,000 shares, with a net sale of 38,979 shares. During the past 18 months, 752,955 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 732,955 shares.
Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ionis Pharmaceuticals Inc Insider Transactions
Stanley T Crooke Mailing Address
Above is the net worth, insider trading, and ownership report for Stanley T Crooke. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Stanley T Crooke's mailing address is: Carlsbad Ca 92010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
